Michael S Weiss insider trades
Open-market stock purchases and sales by Michael S Weiss, Executive Vice Chairman at Fortress Biotech, Inc, from SEC Form 4 filings since Apr 5, 2010.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +138%.
Companies traded
- FBIO Fortress Biotech, Inc: 2 buys, last Mar 18, 2026
- TGTX TG Therapeutics, Inc: 5 buys, 3 sales, last Jan 8, 2026
- CKPT Checkpoint Therapeutics, Inc: other filings, last May 30, 2025
- MBIO Mustang BIO, Inc: other filings, last Jul 5, 2023
- ATXI Avenue Therapeutics, Inc: other filings, last Aug 7, 2018
- CNDO Coronado Biosciences Inc: 1 buy, last Nov 6, 2014
- [CNDO] Coronado Biosciences Inc: other filings, last Feb 20, 2014
- TGTXD TG Therapeutics, Inc: 1 buy, last May 16, 2012
- KERX Keryx Biopharmaceuticals Inc: 10 sales, last May 10, 2010